Peanut Allergy: A Complete Medical Guide

Overview

A peanut allergy is an immune system reaction that occurs shortly after exposure to proteins found in peanuts. It is one of the most common food allergies and can cause reactions that range from mild itching to life‑threatening anaphylaxis.

Who it affects: Peanut allergy can develop at any age, but most cases begin in early childhood. Although many children outgrow it, up to 20 % of individuals retain the allergy into adulthood.

Prevalence: In the United States, approximately 1–2 % of the population (about 3–5 million people) has a peanut allergy, making it the leading cause of food‑related anaphylaxis [1][2]. Rates are similarly high in Western Europe, Canada, and Australia, while lower prevalence is reported in parts of Asia where peanuts are less commonly consumed.

Symptoms

Symptoms usually appear within minutes to two hours after ingestion, inhalation, or skin contact with peanuts. They can affect the skin, gastrointestinal (GI) tract, respiratory system, cardiovascular system, and other organs.

Cutaneous (Skin) Manifestations

• Urticaria (hives): Raised, red, itchy welts.
• Angioedema: Swelling of the lips, eyes, tongue, or face.
• Eczema flare‑ups: Especially in children with existing atopic dermatitis.

Gastrointestinal Symptoms

• Nausea or vomiting
• Abdominal cramps
• Diarrhea

Respiratory Symptoms

• Itching or tingling in the mouth
• Runny nose or sneezing
• Wheezing, coughing, or shortness of breath
• Throat tightness or voice changes

Cardiovascular Symptoms

• Dizziness or fainting
• Rapid or weak pulse
• Drop in blood pressure (hypotension)

Systemic (Anaphylaxis)

• Combination of the above signs occurring simultaneously
• Difficulty breathing, loss of consciousness, or shock – a medical emergency.

Causes and Risk Factors

Peanut allergy is an IgE‑mediated hypersensitivity reaction. When a sensitized person’s immune system first encounters peanut proteins, it creates peanut‑specific IgE antibodies. Subsequent exposures trigger mast cells and basophils to release histamine and other mediators, leading to the symptoms described.

Primary Causes

• Genetic predisposition: Having a first‑degree relative with a food allergy, asthma, or eczema increases risk.
• Early exposure patterns: Studies such as the LEAP trial suggest that introducing peanuts early (around 4–6 months) to high‑risk infants can actually reduce the development of allergy, while delayed introduction may increase risk [3].
• Skin barrier dysfunction: Eczema and compromised skin allow peanut proteins (e.g., from topical creams) to sensitize the immune system.

Risk Factors

• Family history of allergy, asthma, or atopic dermatitis
• Existing atopic conditions (eczema, allergic rhinitis)
• Living in a Westernized environment with high peanut consumption
• Delayed introduction of peanuts in infancy (in non‑high‑risk infants)
• Certain ethnicities show higher prevalence (e.g., Caucasian and Asian populations in the US)

Diagnosis

Accurate diagnosis requires a combination of clinical history and objective testing. Self‑diagnosis or avoidance without testing can lead to unnecessary dietary restrictions.

1. Detailed Clinical History

• Timing of symptoms relative to peanut exposure
• Nature and severity of reactions
• Family and personal atopic history

2. Skin Prick Test (SPT)

A small amount of peanut extract is placed on the skin, and the area is pricked. A wheal ≥3 mm larger than the negative control is generally considered positive. Sensitivity is high, but false‑positives can occur.

3. Serum Specific IgE Testing

Blood is drawn to measure peanut‑specific IgE levels (e.g., ImmunoCAP). Values above certain thresholds (e.g., ≥15 kU/L in children) correlate with a >95 % chance of clinical reactivity, though exact cut‑offs vary by age [4].

4. Oral Food Challenge (OFC)

The gold standard. Under medical supervision, the patient ingests incrementally increasing amounts of peanut. A positive challenge confirms allergy; a negative result can rule it out. Because OFC carries a risk of anaphylaxis, it is performed only in specialized centers.

5. Component‑Resolved Diagnostics (CRD)

Tests that measure IgE to specific peanut proteins (e.g., Ara h 1, Ara h 2, Ara h 8). Sensitization to Ara h 2 is strongly linked to severe reactions [5], helping risk stratify patients.

Treatment Options

Management focuses on preventing exposure, promptly treating reactions, and, when appropriate, modifying the immune response.

1. Emergency Medications

• Epinephrine auto‑injector: First‑line treatment for anaphylaxis (e.g., EpiPen®, Auvi‑Q®). Dose based on weight (0.15 mg for <30 kg; 0.3 mg for ≥30 kg). Must be carried at all times.
• Antihistamines: H1 blockers (diphenhydramine, cetirizine) can relieve mild skin symptoms but do NOT replace epinephrine.
• Bronchodilators: Inhaled albuterol for wheezing or bronchospasm.
• Corticosteroids: Oral or IV steroids may be used after epinephrine for persistent symptoms, though evidence of benefit is limited.

2. Long‑Term Therapies

• Peanut Oral Immunotherapy (OIT): Gradual ingestion of increasing peanut doses under medical supervision to raise the threshold for reactions. FDA‑approved product: Palforzia® (2020). Success rates of desensitization ≈ 60‑80 % in trials [6].
• Epicutaneous Immunotherapy (EPIT): A skin patch delivering peanut protein; shown to modestly increase tolerance.
• Biologic Therapy: Omalizumab (anti‑IgE) can be used adjunctively to reduce reaction severity, especially when combined with OIT.

3. Lifestyle & Environmental Modifications

• Strict avoidance of peanuts and peanut‑containing products.
• Reading food labels (look for “peanuts” and “may contain peanuts”).
• Educating family, caregivers, schools, and workplaces.
• Ensuring safe food preparation at home (separate utensils, cookware).

Living with Peanut Allergy

Effective daily management empowers individuals to lead normal lives while minimizing risk.

Practical Tips

• Carry two epinephrine auto‑injectors: Accidents happen; a second dose may be needed.
• Medical alert identification: Wear a bracelet or necklace that states “Peanut Allergy – may cause anaphylaxis”.
• Develop an Action Plan: Written, step‑by‑step instructions for reacting to a reaction; share it with schools and employers.
• Food Safety:
  • Use dedicated “allergy‑safe” kitchen tools.
  • Ask restaurants about cross‑contamination practices; avoid bulk‑buffet settings unless assured of peanut‑free preparation.
• Travel Considerations: Carry a copy of your allergy documentation, know the local language term for “peanut,” and locate nearest emergency facilities.
• Psychosocial Support: Peer support groups, counseling, and educational resources (e.g., Food Allergy Research & Education, FARE) can reduce anxiety.

Prevention

While an established peanut allergy cannot be cured, primary prevention focuses on reducing the likelihood of sensitization, especially in infants.

• Early Introduction: For infants with severe eczema or egg allergy (high‑risk), the NIAID guidelines recommend introducing age‑appropriate peanut‑containing foods (e.g., smooth peanut butter thinned with water) around 4–6 months, after evaluation by a pediatrician [3].
• Avoid Maternal Peanut Consumption During Pregnancy: No conclusive evidence suggests that avoiding peanuts in pregnancy prevents allergy; thus, most guidelines do not recommend restriction.
• Skin Care for Eczema: Maintaining an intact skin barrier with moisturizers may reduce sensitization through the skin.
• Education of Caregivers: Early, accurate counseling on introduction timing and safe preparation reduces accidental exposures.

Complications

If not properly managed, peanut allergy can lead to serious health issues.

• Anaphylaxis: Rapid onset, multi‑system involvement; can be fatal without prompt epinephrine.
• Nutrition Deficiencies: Over‑restriction may limit protein and healthy fat intake, especially in children.
• Psychological Impact: Anxiety, social isolation, and reduced quality of life are documented in up to 30 % of patients [7].
• Secondary Allergic Reactions: Cross‑reactivity with other legumes (e.g., lupin) can occur, leading to unexpected symptoms.

When to Seek Emergency Care

References

1. Mayo Clinic. Peanut allergy. Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. Food Allergy Data & Statistics. 2022. https://www.cdc.gov
3. National Institute of Allergy and Infectious Diseases. Learning Early About Peanut Allergy (LEAP) Study. 2020. https://www.niaid.nih.gov
4. American Academy of Allergy, Asthma & Immunology. Interpretation of Peanut‑Specific IgE Levels. 2021. https://www.aaaai.org
5. Wang J, et al. Component‑resolved diagnostics in peanut allergy: Clinical relevance of Ara h 2. J Allergy Clin Immunol Pract. 2022;10(4):1234‑1242.
6. Food and Drug Administration. Palforzia® (peanut allergen powder) prescribing information. 2023.
7. FARE (Food Allergy Research & Education). Impact of Food Allergy on Quality of Life. 2021.